Laboratory Corporation of America Holdings (0JSY.L)
USD 225.47
(2.86%)
USD 225.47
(2.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 725.6 Million USD | -36.65% |
| 2022 | 1.77 Billion USD | -45.58% |
| 2021 | 3.25 Billion USD | 33.29% |
| 2020 | 2.44 Billion USD | 83.84% |
| 2019 | 1.33 Billion USD | 0.34% |
| 2018 | 1.32 Billion USD | -2.82% |
| 2017 | 1.36 Billion USD | 3.95% |
| 2016 | 1.31 Billion USD | 30.86% |
| 2015 | 1 Billion USD | 10.16% |
| 2014 | 910.4 Million USD | -8.12% |
| 2013 | 990.9 Million USD | -3.19% |
| 2012 | 1.02 Billion USD | 7.92% |
| 2011 | 948.4 Million USD | -3.11% |
| 2010 | 978.8 Million USD | 4.58% |
| 2009 | 935.9 Million USD | 11.03% |
| 2008 | 842.9 Million USD | 8.48% |
| 2007 | 777 Million USD | 11.46% |
| 2006 | 697.1 Million USD | 12.78% |
| 2005 | 618.1 Million USD | 3.29% |
| 2004 | 598.4 Million USD | 12.12% |
| 2003 | 533.7 Million USD | 22.69% |
| 2002 | 435 Million USD | 18.34% |
| 2001 | 367.6 Million USD | 46.98% |
| 2000 | 250.1 Million USD | 67.07% |
| 1999 | 149.7 Million USD | 17.32% |
| 1998 | 127.6 Million USD | 238.7% |
| 1997 | -92 Million USD | 3.97% |
| 1996 | -95.8 Million USD | -242.56% |
| 1995 | 67.2 Million USD | -38.85% |
| 1994 | 109.9 Million USD | -40.75% |
| 1993 | 185.5 Million USD | -7.3% |
| 1992 | 200.1 Million USD | 15.33% |
| 1991 | 173.5 Million USD | 23.58% |
| 1990 | 140.4 Million USD | 24.47% |
| 1989 | 112.8 Million USD | -64.06% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 306.4 Million USD | -6.81% |
| 2024 Q2 | 254.1 Million USD | -17.07% |
| 2023 Q3 | 229.3 Million USD | -9.12% |
| 2023 Q2 | 252.3 Million USD | -5.26% |
| 2023 Q1 | 266.3 Million USD | -21.91% |
| 2023 Q4 | 328.8 Million USD | 43.39% |
| 2023 FY | 1.12 Billion USD | -36.65% |
| 2022 FY | 1.77 Billion USD | -45.58% |
| 2022 Q1 | 525.9 Million USD | -23.55% |
| 2022 Q2 | 469.4 Million USD | -10.74% |
| 2022 Q3 | 374.1 Million USD | -20.3% |
| 2022 Q4 | 341 Million USD | -8.85% |
| 2021 Q1 | 704.1 Million USD | -33.44% |
| 2021 Q2 | 766.9 Million USD | 8.92% |
| 2021 Q3 | 730.6 Million USD | -4.73% |
| 2021 Q4 | 687.9 Million USD | -5.84% |
| 2021 FY | 3.25 Billion USD | 33.29% |
| 2020 FY | 2.44 Billion USD | 83.84% |
| 2020 Q3 | 1.29 Billion USD | 23.5% |
| 2020 Q2 | 1.04 Billion USD | 251.73% |
| 2020 Q4 | 1.05 Billion USD | -18.2% |
| 2020 Q1 | 297.7 Million USD | 254.57% |
| 2019 Q3 | 336.4 Million USD | -1.03% |
| 2019 Q4 | -192.6 Million USD | -157.25% |
| 2019 FY | 1.33 Billion USD | 0.34% |
| 2019 Q1 | 335.7 Million USD | 5.5% |
| 2019 Q2 | 339.9 Million USD | 1.25% |
| 2018 Q2 | 343.4 Million USD | -6.99% |
| 2018 FY | 1.32 Billion USD | -2.82% |
| 2018 Q4 | 318.2 Million USD | 3.41% |
| 2018 Q3 | 307.7 Million USD | -10.4% |
| 2018 Q1 | 369.2 Million USD | 20.89% |
| 2017 Q4 | 305.4 Million USD | -13.78% |
| 2017 FY | 1.36 Billion USD | 3.95% |
| 2017 Q1 | 336 Million USD | 0.99% |
| 2017 Q3 | 354.2 Million USD | 3.78% |
| 2017 Q2 | 341.3 Million USD | 1.58% |
| 2016 FY | 1.31 Billion USD | 30.86% |
| 2016 Q2 | 324 Million USD | -11.69% |
| 2016 Q4 | 332.7 Million USD | 2.88% |
| 2016 Q3 | 323.4 Million USD | -0.19% |
| 2016 Q1 | 366.9 Million USD | 21.53% |
| 2015 Q3 | 243.5 Million USD | -20.66% |
| 2015 FY | 1 Billion USD | 10.16% |
| 2015 Q4 | 301.9 Million USD | 23.98% |
| 2015 Q1 | 321.3 Million USD | 146.77% |
| 2015 Q2 | 306.9 Million USD | -4.48% |
| 2014 Q2 | 241.4 Million USD | -2.15% |
| 2014 Q1 | 246.7 Million USD | 21.35% |
| 2014 Q3 | 219 Million USD | -9.28% |
| 2014 FY | 910.4 Million USD | -8.12% |
| 2014 Q4 | 130.2 Million USD | -40.55% |
| 2013 Q2 | 244.6 Million USD | -9.17% |
| 2013 FY | 990.9 Million USD | -3.19% |
| 2013 Q4 | 203.3 Million USD | -5.44% |
| 2013 Q1 | 269.3 Million USD | 2.79% |
| 2013 Q3 | 215 Million USD | -12.1% |
| 2012 Q4 | 262 Million USD | 21.69% |
| 2012 FY | 1.02 Billion USD | 7.92% |
| 2012 Q3 | 215.3 Million USD | -12.16% |
| 2012 Q2 | 245.1 Million USD | -11.2% |
| 2012 Q1 | 276 Million USD | -3.87% |
| 2011 Q4 | 287.1 Million USD | 16.0% |
| 2011 FY | 948.4 Million USD | -3.11% |
| 2011 Q3 | 247.5 Million USD | 3.38% |
| 2011 Q1 | 225.7 Million USD | -4.28% |
| 2011 Q2 | 239.4 Million USD | 6.07% |
| 2010 Q3 | 238.8 Million USD | 1.49% |
| 2010 FY | 978.8 Million USD | 4.58% |
| 2010 Q4 | 235.8 Million USD | -1.26% |
| 2010 Q1 | 270.5 Million USD | 15.5% |
| 2010 Q2 | 235.3 Million USD | -13.01% |
| 2009 FY | 935.9 Million USD | 11.03% |
| 2009 Q4 | 234.2 Million USD | 8.53% |
| 2009 Q3 | 215.8 Million USD | -8.13% |
| 2009 Q2 | 234.9 Million USD | -4.0% |
| 2009 Q1 | 244.7 Million USD | 1.75% |
| 2008 FY | 842.9 Million USD | 8.48% |
| 2008 Q4 | 240.5 Million USD | 17.66% |
| 2008 Q1 | 195.2 Million USD | -19.04% |
| 2008 Q2 | 202.2 Million USD | 3.59% |
| 2008 Q3 | 204.4 Million USD | 1.09% |
| 2007 Q3 | 182.2 Million USD | 1.84% |
| 2007 FY | 777 Million USD | 11.46% |
| 2007 Q1 | 212.5 Million USD | 4.47% |
| 2007 Q2 | 178.9 Million USD | -15.81% |
| 2007 Q4 | 241.1 Million USD | 32.33% |
| 2006 FY | 697.1 Million USD | 12.78% |
| 2006 Q4 | 203.4 Million USD | 25.02% |
| 2006 Q3 | 162.7 Million USD | -7.56% |
| 2006 Q2 | 176 Million USD | -7.17% |
| 2006 Q1 | 189.6 Million USD | 12.32% |
| 2005 Q3 | 135.8 Million USD | -10.42% |
| 2005 Q2 | 151.6 Million USD | -12.42% |
| 2005 Q4 | 168.8 Million USD | 24.3% |
| 2005 Q1 | 173.1 Million USD | 9.84% |
| 2005 FY | 618.1 Million USD | 3.29% |
| 2004 Q2 | 152.8 Million USD | -6.94% |
| 2004 FY | 598.4 Million USD | 12.12% |
| 2004 Q4 | 157.6 Million USD | 14.95% |
| 2004 Q1 | 164.2 Million USD | 13.79% |
| 2004 Q3 | 137.1 Million USD | -10.27% |
| 2003 Q1 | 142.9 Million USD | 14.6% |
| 2003 Q3 | 130.7 Million USD | -3.47% |
| 2003 Q2 | 135.4 Million USD | -5.25% |
| 2003 FY | 533.7 Million USD | 22.69% |
| 2003 Q4 | 144.3 Million USD | 10.41% |
| 2002 Q2 | 96.2 Million USD | -28.26% |
| 2002 Q1 | 134.1 Million USD | 15.21% |
| 2002 Q3 | 88.3 Million USD | -8.21% |
| 2002 Q4 | 124.7 Million USD | 41.22% |
| 2002 FY | 435 Million USD | 18.34% |
| 2001 FY | 367.6 Million USD | 46.98% |
| 2001 Q4 | 116.4 Million USD | 50.39% |
| 2001 Q3 | 77.4 Million USD | -22.83% |
| 2001 Q1 | 102.6 Million USD | 17.53% |
| 2001 Q2 | 100.3 Million USD | -2.24% |
| 2000 Q4 | 87.3 Million USD | 67.56% |
| 2000 Q1 | 71.3 Million USD | 24.22% |
| 2000 FY | 250.1 Million USD | 67.07% |
| 2000 Q2 | 69.3 Million USD | -2.81% |
| 2000 Q3 | 52.1 Million USD | -24.82% |
| 1999 Q2 | 40.1 Million USD | -4.75% |
| 1999 FY | 149.7 Million USD | 17.32% |
| 1999 Q4 | 57.4 Million USD | 73.41% |
| 1999 Q3 | 33.1 Million USD | -17.46% |
| 1999 Q1 | 42.1 Million USD | 22.38% |
| 1998 Q3 | 26.6 Million USD | -22.45% |
| 1998 Q2 | 34.3 Million USD | -8.29% |
| 1998 Q4 | 34.4 Million USD | 29.32% |
| 1998 Q1 | 37.4 Million USD | 27.21% |
| 1998 FY | 127.6 Million USD | 238.7% |
| 1997 Q1 | 30.9 Million USD | 11.15% |
| 1997 FY | -92 Million USD | 3.97% |
| 1997 Q4 | 29.4 Million USD | 116.58% |
| 1997 Q3 | -177.3 Million USD | -764.04% |
| 1997 Q2 | 26.7 Million USD | -13.59% |
| 1996 Q1 | 20.1 Million USD | -27.7% |
| 1996 FY | -95.8 Million USD | -242.56% |
| 1996 Q4 | 27.8 Million USD | 117.02% |
| 1996 Q3 | -163.3 Million USD | -933.16% |
| 1996 Q2 | 19.6 Million USD | -2.49% |
| 1995 Q2 | 43.2 Million USD | -3.57% |
| 1995 Q4 | 27.8 Million USD | 148.35% |
| 1995 Q1 | 44.8 Million USD | 22.07% |
| 1995 FY | 67.2 Million USD | -38.85% |
| 1995 Q3 | -57.5 Million USD | -233.1% |
| 1994 Q4 | 36.7 Million USD | 39.54% |
| 1994 Q2 | 34.5 Million USD | 13.11% |
| 1994 Q1 | 30.5 Million USD | 63.98% |
| 1994 FY | 109.9 Million USD | -40.75% |
| 1994 Q3 | 26.3 Million USD | -23.77% |
| 1993 Q1 | 57.3 Million USD | 0.0% |
| 1993 Q4 | 18.6 Million USD | 8.14% |
| 1993 Q3 | 17.2 Million USD | -67.97% |
| 1993 Q2 | 53.7 Million USD | -6.28% |
| 1993 FY | 185.5 Million USD | -7.3% |
| 1992 Q3 | 42.5 Million USD | -18.43% |
| 1992 Q1 | 52.1 Million USD | 1.56% |
| 1992 Q2 | 52.1 Million USD | 0.0% |
| 1992 FY | 200.1 Million USD | 15.33% |
| 1992 Q4 | 57.3 Million USD | 34.82% |
| 1991 Q4 | 51.3 Million USD | 4.06% |
| 1991 FY | 173.5 Million USD | 23.58% |
| 1991 Q2 | 41.5 Million USD | -4.38% |
| 1991 Q3 | 49.3 Million USD | 18.8% |
| 1991 Q1 | 43.4 Million USD | 10.43% |
| 1990 Q4 | 39.3 Million USD | -3.68% |
| 1990 Q2 | 32.1 Million USD | -7.49% |
| 1990 FY | 140.4 Million USD | 24.47% |
| 1990 Q1 | 34.7 Million USD | 5.79% |
| 1990 Q3 | 40.8 Million USD | 27.1% |
| 1989 Q3 | 33.1 Million USD | 33.47% |
| 1989 FY | 112.8 Million USD | -64.06% |
| 1989 Q4 | 32.8 Million USD | -0.91% |
| 1989 Q1 | 28.4 Million USD | 7.17% |
| 1989 Q2 | 24.8 Million USD | -12.68% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 650.644% |
| Accuray Incorporated | 504 Thousand USD | -143868.254% |
| Align Technology, Inc. | 643.33 Million USD | -12.787% |
| Elevance Health Inc. | 133.96 Billion USD | 99.458% |
| AxoGen, Inc. | -21.46 Million USD | 3480.859% |
| Boston Scientific Corporation | 2.34 Billion USD | 69.031% |
| CVS Health Corporation | 13.74 Billion USD | 94.72% |
| Cardinal Health, Inc. | 1.24 Billion USD | 41.625% |
| Centene Corporation | 2.93 Billion USD | 75.235% |
| DaVita Inc. | 1.6 Billion USD | 54.729% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 92.463% |
| Hologic, Inc. | 970.2 Million USD | 25.211% |
| Humana Inc. | 4.01 Billion USD | 81.919% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 33.864% |
| Masimo Corporation | 136.5 Million USD | -431.575% |
| McKesson Corporation | 3.9 Billion USD | 81.438% |
| Patterson Companies, Inc. | 252.92 Million USD | -186.885% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 42.504% |
| ResMed Inc. | 1.31 Billion USD | 45.026% |
| Henry Schein, Inc. | 615 Million USD | -17.984% |
| Teladoc Health, Inc. | -248.55 Million USD | 391.93% |
| Universal Health Services, Inc. | 1.17 Billion USD | 38.267% |
| Veeva Systems Inc. | 429.33 Million USD | -69.006% |
| Baxter International Inc. | 390 Million USD | -86.051% |
| Becton, Dickinson and Company | 2.11 Billion USD | 65.628% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 58.931% |
| Danaher Corporation | 5.38 Billion USD | 86.516% |
| Stryker Corporation | 3.88 Billion USD | 81.337% |
| Medtronic plc | 5.14 Billion USD | 85.894% |